A new study highlights the scale and scope of the Trump administration’s termination of National Cancer Institute (NCI) research grants since it slashed cancer research funding in early 2025 and cut ...

Bladder cancer is the sixth most commonly diagnosed cancer in the United States. More than 90% of bladder cancers are urothelial carcinomas, cancers that arise in cells that line the bladder.

Carranza, a child development professional who grew up swinging through trees and swimming in rivers in El Salvador, said she feels at home in the forest at the outdoor preschool she co-founded. She ...

The researchers found that for men with low PSA levels prior to radiotherapy, adding hormone therapy, whether short-term or long-term, did not improve overall survival. Men with higher PSA levels ...

When we set about to enhance SEER, we worked with and sought feedback from many groups and experts. This outreach allowed us to better understand the cancer research community’s needs and the ...

But in fact, research on personalized cancer vaccines, designed to help the immune system recognize and attack tumors, has been underway for at least a decade. Scientists have reported promising ...

“The goal of this study is not to divert funds away from cancers that are well supported, but rather expand funding for other cancers that aren’t getting enough support currently,” lead author Suneel ...

The latest study, titled “A global perspective on coal-fired power plants and burden of lung cancer,” published in the journal Environmental Health, looked at data from 13,581 coal-fired plants in 83 ...

Women who received chemotherapy for lymphoma in the afternoon instead of in the morning appeared to respond better and had fewer side effects, according to a study published in JCI Insight. Women ...

The FDA initially approved Enhertu in December 2019 for inoperable or metastatic breast cancer with high HER2 expression. Approval was extended to patients with HER2-low breast cancer in August 2022, ...

Shield “has limited detection (55% to 65%) of Stage I colorectal cancer and does not detect 87% of precancerous lesions,” notes the FDA. “The test is used for [colorectal] screening in individuals at ...

Edward Ratner, 68, a geriatrician, husband, father and grandfather in Minneapolis, has had chronic lymphocytic leukemia for a decade. Here, he shares his story—and his rules for success.